Kurve Active Project List
Dosing in Humans.
Intranasal Insulin Therapy for Alzheimer Disease and Amnestic Mild Cognitive Impairment
Intranasal insulin improves cognition and modulates β-amyloid in early AD
The results of this pilot study support further investigation of the benefits of intranasal
insulin for patients with Alzheimer disease, and suggest that intranasal peptide administration
may be a novel approach to the treatment of neurodegenerative disorders.
Superior deposition in gamma scintigraphy studies
Gamma scintigraphy studies have confirmed Controlled Particle Dispersion's
unique ability to saturate the entire nasal cavity, including the
olfactory regions and the paranasal sinuses. Read more
Clinical efficacy in Alzheimer's study
Insulin delivered by ViaNase shows promise for patients with Alzheimers and
Mild Cognitive Impairment. Read more
Live virus potency maintained in CDC study
Download a technical brochure on Controlled Particle Dispersion